The DOI matches its Crossref record; 57 of the 58 references it cites were found in a registry or an index.
The transcription factor PU.1 is critical for viability and function of human brain microglia
Abstract
Microglia are the predominant resident immune cells of the brain and can assume a range of phenotypes. They are critical for normal brain development and function but can also contribute to many disease processes. Although they are widely studied, the transcriptional control of microglial phenotype and activation requires further research. PU.1 is a key myeloid transcription factor expressed by peripheral macrophages and rodent microglia. In this article, we report the presence of PU.1 specifically in microglia of the adult human brain and we examine its functional role in primary human microglia. Using siRNA, we achieved substantial PU.1 protein knock‐down in vitro . By assessing a range of characteristic microglial proteins we found decreased viability of adult human microglia with reduced PU.1 protein expression. This observation was confirmed with PU.1 antisense DNA oligonucleotides. An important function of microglia is to clear debris by phagocytosis. We assessed the impact of loss of PU.1 on microglial phagocytosis and show that PU.1 siRNA reduces the ability of adult human microglia to phagocytose amyloid‐beta 1‐42 peptide. These results show that PU.1 controls human microglial viability and function and suggest PU.1 as a molecular target for manipulation of human microglial phenotype.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In particular, PU.1 expression is dynamically and tightly controlled during haematopoiesis to direct the specification of CD34+ hematopoietic stem and progenitor cells toward the myeloid and B-lymphoid lineage by progressively partitioning into CD14+ monocytes/macrophages, CD15+ neutrophils, and CD19+ B cells46”
From A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's disease (2017) · cites this paper as [46]
In the citing paper
“which is well known for its pivotal role in microglial development and inflammation (Fig. 7, D to F) (15, 40).”
From Arresting the bad seed: HDAC3 regulates proliferation of different microglia after ischemic stroke (2024) · cites this paper as [40]
In the citing paper
“We have previously reported that PU.1 regulates zymosan phagocytosis (Huang et al., 2017) and others reported that PU.1 knock-down reduces Aβ42 uptake in human microglial cells (Smith et al., 2013).”
From Alzheimer's-associated PU.1 expression levels regulate microglial inflammatory response (2021) · cites this paper as Smith et al., 2013
In the citing paper
“In primary human microglia cultures siRNA mediated reductions in PU.1 resulted in a decrease in Amyloid-β 1-42 peptide phagocytosis41, in a similar manner to observations in BV-2 cells7,32.”
From Modest changes in Spi1 dosage reveal the potential for altered microglial function as seen in Alzheimer’s disease (2021) · cites this paper as [41]
In the citing paper
“Overall, this reinforces previous reports that reduced Spi1 seems to impact cell cycle which was not unexpected given the involvement of PU.1 in survival signalling11,41.”
From Modest changes in Spi1 dosage reveal the potential for altered microglial function as seen in Alzheimer’s disease (2021) · cites this paper as [41]
In the citing paper
“In human microglia cultures an siRNA mediated reduction of PU.1 resulted in a lower cell number, disintegration and rounding of some cells but at the final timepoint viability appeared unaffected. This suggests some microglia could survive with reduced PU.141.”
From Modest changes in Spi1 dosage reveal the potential for altered microglial function as seen in Alzheimer’s disease (2021) · cites this paper as [41]
In the citing paper
“silencing of PU.1 by siRNA in mixed human glial culture led to the reduced viability of microglia and decreased phagocytosis of amyloid-beta (A β 42) (Smith, Gibbons et al., 2013).”
From Pu.1/Spi1 dosage controls the turnover and maintenance of microglia in zebrafish and mammals (2023) · cites this paper as Smith, Gibbons et al., 2013
In the citing paper
“silencing of PU.1 by siRNA in mixed human glial culture led to the reduced viability of microglia and decreased phagocytosis of amyloid-beta (Aβ42) (Smith et al., 2013).”
From Pu.1/Spi1 dosage controls the turnover and maintenance of microglia in zebrafish and mammals (2025) · cites this paper as Smith et al., 2013
In the citing paper
“On the contrary, Spi1-knockdown also decreases microglial phagocytic activity in vitro, which may lead to an increase in the levels of toxic protein aggregates and dead cell debris1,7.”
From Effects of SPI1-mediated transcriptome remodeling on Alzheimer's disease-related phenotypes in mouse models of Aβ amyloidosis (2024) · cites this paper as [7]
In the citing paper
“Human genetic studies suggest that reduced SPI1 expression may be protective, whereas experimental data indicate that excessive PU.1 suppression can impair essential microglial functions.”
From Lymphoid-like Suppressive Microglia in Alzheimer’s Disease: A New Neuroimmune Regulatory Axis? (2026) · cites this paper as [32]
In the citing paper
“Because PU.1 is required for microglial identity and viability, excessive reduction may impair essential functions.”
From Lymphoid-like Suppressive Microglia in Alzheimer’s Disease: A New Neuroimmune Regulatory Axis? (2026) · cites this paper as [32]
In the citing paper
“This creates a central tension for Alzheimer’s therapeutics: lowering PU.1 may reduce risk-associated or inflammatory programs, but too much suppression could compromise microglial survival, plaque engagement, phagocytosis, or other protective functions.”
From Lymphoid-like Suppressive Microglia in Alzheimer’s Disease: A New Neuroimmune Regulatory Axis? (2026) · cites this paper as [32]
In the citing paper
“Earlier work in human microglia showed that PU.1 is critical for microglial viability and expression of characteristic microglial proteins, indicating that PU.1 cannot be viewed only as a disease-promoting factor [32].”
From Lymphoid-like Suppressive Microglia in Alzheimer’s Disease: A New Neuroimmune Regulatory Axis? (2026) · cites this paper as [32]
In the citing paper
“Previous studies investigating the therapeutic potential of PU.1 for Alzheimer's disease have relied primarily on in vitro experiments using cell culture systems [22, 37, 38].”
From Targeting Microglial Transcriptional Reprogramming as a Therapy Strategy for Alzheimer's Disease (2026) · cites this paper as [38]
In the citing paper
“On the other hand, PU.1 positively regulates phagocytosis, a potentially beneficial process critical for Aβ clearance in Alzheimer's disease pathology [37, 38].”
From Targeting Microglial Transcriptional Reprogramming as a Therapy Strategy for Alzheimer's Disease (2026) · cites this paper as [38]
In the citing paper
“in early‐stage Alzheimer's disease, increasing PU.1 activity may enhance microglial amyloid clearance”
From Targeting Microglial Transcriptional Reprogramming as a Therapy Strategy for Alzheimer's Disease (2026) · cites this paper as [38]
In the citing paper
“Mutant HTT expression in R6/2 microglia effectively 'primes' the cell by increasing expression of the myeloid transcription factor Pu.1”
From Microglial depletion prevents extracellular matrix changes and striatal volume reduction in a model of Huntington's disease (2020) · cites this paper as Smith et al., 2013
In the citing paper
“However, silencing of PU.1 by siRNA reduced the number of microglia and their ramification and phagocytosis of amyloid-beta peptide 1-42 (AB42) in mixed glial culture in their study [29].”
From Transcriptional and Epigenetic Regulation of Microglia in Health and Disease (2019) · cites this paper as [29]
In the citing paper
“PU.1 expression levels are similar in isolated human glial cells from biopsy and postmortem adult human brain tissues [29].”
From Transcriptional and Epigenetic Regulation of Microglia in Health and Disease (2019) · cites this paper as [29]
In the citing paper
“which is necessary for microglial differentiation and maintenance 21,22 and can induce macrophages from fibroblasts 23.”
From Efficient derivation of microglia-like cells from human pluripotent stem cells (2016) · cites this paper as [22]
Citations
Cites
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827
Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages
Ginhoux, F., Greter, M., Leboeuf, M., Nandi, S., See, P., Gokhan, S., Mehler, M. F., Conway, S. J., Ng, L. G., Stanley, E. R., et al. (2010) · Science · doi:10.1126/science.1194637 · Cited by 5,175
Microglia: Active sensor and versatile effector cells in the normal and pathologic brain
Hanisch, U.-K., & Kettenmann, H. (2007) · Nature Neuroscience · doi:10.1038/nn1997 · Cited by 3,676
Bard, F., Cannon, C., Barbour, R., Burke, R.-L., Games, D., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., et al. (2000) · Nature Medicine · doi:10.1038/78682 · Cited by 2,012
Microglial cell origin and phenotypes in health and disease
Saijo, K., & Glass, C. K. (2011) · Nature Reviews Immunology · doi:10.1038/nri3086 · Cited by 1,100
Ponomarev, E. D., Veremeyko, T., Barteneva, N., Krichevsky, A. M., & Weiner, H. L. (2011) · Nature Medicine · doi:10.1038/nm.2266 · Cited by 787
Microglia and neurodegeneration: The role of systemic inflammation
Cunningham, C. (2013) · Glia · doi:10.1002/glia.22350 · Cited by 769
Graeber, M. B. (2010) · Science · doi:10.1126/science.1190929 · Cited by 608
Comparison of polarization properties of human adult microglia and blood‐derived macrophages
Durafourt, B. A., Moore, C. S., Zammit, D., Johnson, T., Zaguia, F., Guiot, M., Bar‐Or, A., & Antel, J. P. (2012) · Glia · doi:10.1002/glia.22298 · Cited by 470
Hematopoietic origin of pathological grooming in Hoxb8 mutant mice
Chen, S.-K., Tvrdik, P., Peden, E., Cho, S., Wu, S., Spangrude, G., & Capecchi, M. R. (2010) · Cell · doi:10.1016/j.cell.2010.03.055 · Cited by 450
Microglial activation in presymptomatic Huntington's disease gene carriers
Tai, Y. F., Pavese, N., Gerhard, A., Tabrizi, S. J., Barker, R. A., Brooks, D. J., & Piccini, P. (2007) · Brain · doi:10.1093/brain/awm044 · Cited by 440
Zhang, D.-E., Hetherington, C. J., Chen, H.-M., & Tenen, D. G. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.1.373-381.1994 · Cited by 411
Microglial senescence: does the brain's immune system have an expiration date?
Streit, W. J. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.07.001 · Cited by 397
Microglia and inflammatory mechanisms in the clearance of amyloid β peptide
Rogers, J., Strohmeyer, R., Kovelowski, C. J., & Li, R. (2002) · Glia · doi:10.1002/glia.10153 · Cited by 381
Inhibition of Microglial Phagocytosis Is Sufficient To Prevent Inflammatory Neuronal Death
Neher, J. J., Neniskyte, U., Zhao, J.-W., Bal-Price, A., Tolkovsky, A. M., & Brown, G. C. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003600 · Cited by 373
PU.1 and C/EBPα/β convert fibroblasts into macrophage-like cells
Feng, R., Desbordes, S. C., Xie, H., Tillo, E. S., Pixley, F., Stanley, E. R., & Graf, T. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711961105 · Cited by 348
The proto-oncogene PU.1 regulates expression of the myeloid-specific CD11b promoter
Pahl, H. L., Scheibe, R. J., Zhang, D. E., Chen, H. M., Galson, D. L., Maki, R. A., & Tenen, D. G. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53496-7 · Cited by 301
Contribution of systemic inflammation to chronic neurodegeneration
Perry, V. H. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0722-x · Cited by 286
Immunohistochemical staining of post-mortem adult human brain sections
Waldvogel, H. J., Curtis, M. A., Baer, K., Rees, M. I., & Faull, R. L. M. (2006) · Nature Protocols · doi:10.1038/nprot.2006.354 · Cited by 211
Self-citation(1995) · PubMed · Cited by 206
Myeloid Development Is Selectively Disrupted in PU.1 Null Mice
Anderson, K. L., Smith, K. A., Conners, K., McKercher, S. R., Maki, R. A., & Torbett, B. E. (1998) · Blood · doi:10.1182/blood.v91.10.3702 · Cited by 193
Therapeutic approaches to inflammation in neurodegenerative disease
Klegeris, A., McGeer, E. G., & McGeer, P. L. (2007) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3280adc943 · Cited by 189
Ebralidze, A. K., Guibal, F. C., Steidl, U. G., Zhang, P., Lee, S., Bartholdy, B., Alberich-Jordà, M., Petkova, V., Rosenbauer, F., Huang, G., et al. (2008) · Genes & Development · doi:10.1101/gad.1654808 · Cited by 183
Wang, X., Scott, E., Sawyers, C. L., & Friedman, A. D. (1999) · Blood · doi:10.1182/blood.v94.2.560 · Cited by 166
The key role of PU.1/SPI-1 in B cells, myeloid cells and macrophages
Lloberas, J., Soler, C., & Celada, A. (1999) · Immunology Today · doi:10.1016/s0167-5699(99)01442-5 · Cited by 142
Neuropathology after active Aβ42 immunotherapy: implications for Alzheimer’s disease pathogenesis
Boche, D., Denham, N., Holmes, C., & Nicoll, J. A. R. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0719-5 · Cited by 135 · cited 1×
“In Alzheimer’s disease microglia may be helpful in clearing the brain of extracellular Ab42 deposits (Bard et al., 2000; Boche et al., 2010; Rogers et al., 2002).”
BackgroundTwo distinct auto-regulatory loops operate at the PU.1 locus in B cells and myeloid cells
Leddin, M., Perrod, C., Hoogenkamp, M., Ghani, S., Assi, S., Heinz, S., Wilson, N. K., Follows, G., Schönheit, J., Vockentanz, L., et al. (2011) · Blood · doi:10.1182/blood-2010-08-302976 · Cited by 131
Macrophage development from HSCs requires PU.1-coordinated microRNA expression
Ghani, S., Riemke, P., Schönheit, J., Lenze, D., Stumm, J., Hoogenkamp, M., Lagendijk, A., Heinz, S., Bonifer, C., Bakkers, J., et al. (2011) · Blood · doi:10.1182/blood-2011-02-335141 · Cited by 123
The adult human brain in preclinical drug development
Dragunow, M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2617 · Cited by 121
Self-citationC/EBPα binds and activates the PU.1 distal enhancer to induce monocyte lineage commitment
Yeamans, C., Wang, D., Paz-Priel, I., Torbett, B. E., Tenen, D. G., & Friedman, A. D. (2007) · Blood · doi:10.1182/blood-2007-03-080291 · Cited by 118
The impact of glial activation in the aging brain.
Lynch, A. M., Murphy, K. J., Deighan, B. F., O’Reilly, J.-A., Gun’ko, Y. K., Cowley, T. R., González-Reyes, R. E., & Lynch, M. A. (2010) · Europe PMC (PubMed Central) · Cited by 103
Huizinga, R., van der Star, B. J., Kipp, M., Jong, R., Gerritsen, W. H., Clarner, T., Puentes, F., Dijkstra, C. D., van der Valk, P., & Amor, S. (2011) · Glia · doi:10.1002/glia.22276 · Cited by 100
Visualizing PU.1 activity during hematopoiesis
Back, J., Allman, D., Chan, S., & Kastner, P. (2005) · Experimental Hematology · doi:10.1016/j.exphem.2004.12.010 · Cited by 97
Cai, D. H., Wang, D., Keefer, J., Yeamans, C., Hensley, K., & Friedman, A. D. (2008) · Oncogene · doi:10.1038/sj.onc.1210940 · Cited by 96
Expression of Fos, Jun, and Krox Family Proteins in Alzheimer's Disease
MacGibbon, G. A., Lawlor, P. A., Walton, M. R., Sirimanne, E. S., Faull, R. L. M., Synek, B. J. L., Mee, E. T., Connor, B. J., & Dragunow, M. (1997) · Experimental Neurology · doi:10.1006/exnr.1997.6600 · Cited by 86
Self-citationYang, T., Zhou, D., & Stefan, H. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.06.002 · Cited by 83
Weigelt, K., Carvalho, L. A., Drexhage, R. C., Wijkhuijs, A. J. M., de Wit, H., van Beveren, N. J. M., Birkenhäger, T. K., Bergink, V., & Drexhage, H. A. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.03.006 · Cited by 76
Walton, M. R., Gibbons, H., MacGibbon, G. A., Sirimanne, E., Saura, J., Gluckman, P. D., & Dragunow, M. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00262-3 · Cited by 73
Self-citationBerclaz, P., Zsengellér, Z. K., Shibata, Y., Otake, K., Strasbaugh, S., Whitsett, J. A., & Trapnell, B. C. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.11.6332 · Cited by 68
Ellis, S. L., Gysbers, V., Manders, P., Li, W., Hofer, M. J., Müller, M., & Campbell, I. L. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000900 · Cited by 58
Cellular composition of human glial cultures from adult biopsy brain tissue
Gibbons, H. M., Hughes, S. M., van Roon‐Mom, W., Greenwood, J. M., Narayan, P. J., Teoh, H. H., Bergin, P., Mee, E. W., Wood, P. C., Faull, R. L. M., et al. (2007) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2007.07.005 · Cited by 55
Self-citationAdult human brain cell culture for neuroscience research
Gibbons, H. M., & Dragunow, M. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.12.002 · Cited by 55
Self-citationValproic acid enhances microglial phagocytosis of amyloid-β1–42
Smith, A. M., Gibbons, H. M., & Dragunow, M. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.04.041 · Cited by 54
Self-citationKummalue, T., & Friedman, A. D. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.1202622 · Cited by 52
Valproic acid induces microglial dysfunction, not apoptosis, in human glial cultures
Gibbons, H. M., Smith, A. M., Teoh, H. H., Bergin, P. M., Mee, E. W., Faull, R. L. M., & Dragunow, M. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.08.024 · Cited by 49
Self-citationBarlic, J., McDermott, D. H., Merrell, M. N., Gonzales, J., Via, L. E., & Murphy, P. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406978200 · Cited by 42
Forsberg, M., Carlén, M., Meletis, K., Yeung, M. S. Y., Barnabé‐Heider, F., Persson, M. A. A., Aarum, J., & Frisén, J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009412107 · Cited by 39
Weigelt, K., Ernst, W., Walczak, Y., Ebert, S., Loenhardt, T., Klug, M., Rehli, M., Weber, B. H. F., & Langmann, T. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0707447 · Cited by 38
Davis, M. M. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003385 · Cited by 35
Cloning and functional characterization of the human fractalkine receptor promoter regions
Garin, A., Pellet, P., Déterre, P., Debré, P., & Combadière, C. (2002) · Biochemical Journal · doi:10.1042/bj20020951 · Cited by 35
Transcriptomic profiling identifies a PU.1 regulatory network in macrophages
Weigelt, K., Lichtinger, M., Rehli, M., & Langmann, T. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.01.067 · Cited by 33
PU.1 is a lineage-specific regulator of tyrosine phosphatase CD45
Anderson, K. L., Nelson, S. L., Perkin, H. B., Smith, K. A., Klemsz, M. J., & Torbett, B. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009133200 · Cited by 32
Identification of three genes up-regulated in PU.1 rescued monocytic precursor cells
Henkel, G. W. (2002) · International Immunology · doi:10.1093/intimm/dxf040 · Cited by 31
A method for generating high-yield enriched neuronal cultures from P19 embryonal carcinoma cells
Monzó, H. J., Park, T., Montgomery, J. M., Faull, R. L. M., Dragunow, M., & Curtis, M. A. (2011) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2011.11.008 · Cited by 30
Self-citationInvolvement of PU.1 in the transcriptional regulation of TNF-α
Fukai, T., Nishiyama, C., Kanada, S., Nakano, N., Hara, M., Tokura, T., Ikeda, S., Ogawa, H., & Okumura, K. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.07.126 · Cited by 27
Koyama, N., Hoelzer, D. F., & Ottmann, O. G. (2004) · European Journal of Immunology · doi:10.1002/eji.200324420 · Cited by 22
PU.1 Regulates the CXCR1 Promoter
Wilkinson, N., & Navarro, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.1.438 · Cited by 17
Cited by
Sorted by citations
An environment-dependent transcriptional network specifies human microglia identity
Gosselin, D., Skola, D., Coufal, N. G., Holtman, I. R., Schlachetzki, J. C. M., Sajti, E., Jaeger, B. N., O’Connor, C., Fitzpatrick, C., Pasillas, M. P., et al. (2017) · Science · doi:10.1126/science.aal3222 · Cited by 1,220
“Within cell-specific enhancers, DNA sequences provide information about the identities of key LDTFs and the activity states of signaling pathways that control the functions of SDTFs (31, 33–35).”
BackgroundInfluentialMicroglia development and function
Nayak, D., Roth, T. L., & McGavern, D. B. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120240 · Cited by 1,154
Efficient derivation of microglia-like cells from human pluripotent stem cells
Muffat, J., Li, Y., Yuan, B., Mitalipova, M., Omer, A., Corcoran, S., Bakiasi, G., Tsai, L.-H., Aubourg, P., Ransohoff, R. M., et al. (2016) · Nature Medicine · doi:10.1038/nm.4189 · Cited by 651
Sublime Microglia: Expanding Roles for the Guardians of the CNS
Salter, M. W., & Beggs, S. (2014) · Cell · doi:10.1016/j.cell.2014.06.008 · Cited by 531
Human microglial state dynamics in Alzheimer’s disease progression
Sun, N., Victor, M. B., Park, Y. P., Xiong, X., Scannail, A. N., Leary, N., Prosper, S., Viswanathan, S., Luna, X., Boix, C. A., et al. (2023) · Cell · doi:10.1016/j.cell.2023.08.037 · Cited by 462
Metadata
- Authors
- Smith, A. M., Gibbons, H. M., Oldfield, R. L., Bergin, P. M., Mee, E. W., Faull, R. L. M., & Dragunow, M.
- Affiliations
- University of Auckland (NZ)
- Lab Plus Auckland New Zealand
- Corresponding author
- Dragunow, Mike
- Venue
- Glia
- Publisher
- Wiley
- Published
- 2013-03-09
- Volume
- 61
- Issue
- 6
- Pages
- 929-942
- ISSN
- 0894-1491 (ISSN-L)
- 1098-1136
- OpenAlex
- W2101108887
- Cited by
- 141
- References
- 58
- Citations by year
- 2026: 12 · 2025: 23 · 2024: 8 · 2023: 12 · 2022: 21 · 2021: 14 · 2020: 13 · 2019: 6 · 2018: 8 · 2017: 7 · 2016: 5 · 2015: 4 · 2014: 5 · 2013: 3
- FWCI
- 2.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Glia (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Keywords
- PU.1, microglia, transcription factors, phagocytosis, amyloid-beta clearance, microglial phenotype, siRNA knockdown, antisense oligonucleotides, human brain
- MeSH terms
- Proto-Oncogene Protein Spi-1, Brain, Cell Survival, Cells, Cultured, Gene Expression Regulation, Humans, Phagocytosis, Proto-Oncogene Proteins, Trans-Activators, Microglia, RNA, Small Interfering
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
